Literature DB >> 11099182

Dynamics of compact denatured states of glutaminyl-tRNA synthetase probed by bis-ANS binding kinetics.

A Bhattacharyya1, A K Mandal, R Banerjee, S Roy.   

Abstract

Bis-ANS binds to native glutaminyl-tRNA synthetase (GlnRS) with a fast and a slow phase. The rate constant of the slow phase is independent of bis-ANS concentration suggesting a slow conformational change in the pathway of bis-ANS binding. Aging of GlnRS causes a large decrease of the slow phase amplitude with concomitant increase of the fast phase amplitude. Several other large, multi-domain proteins show similar patterns upon aging. The near UV-CD spectra of the native and the aged GlnRS remain similar. Significant changes in far UV-CD, acrylamide quenching and sulfhydryl reactivity, are seen upon aging, suggesting disruptions in native interactions. Refolding of GlnRS from the urea-denatured state rapidly produces a state that is very similar to the equilibrium molten globule state. Bis-ANS binds to the molten globule state with kinetics similar to that of the aged state and unlike that of the native state. This suggests that the slow binding phase of bis-ANS, seen in native proteins, originate from relatively high energy barriers between the native and the more open states. Thus bis-ANS can be used as a powerful probe for large amplitude, low-frequency motions of proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11099182     DOI: 10.1016/s0301-4622(00)00192-7

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  2 in total

1.  Dynamics of ANS binding to tuna apomyoglobin measured with fluorescence correlation spectroscopy.

Authors:  E Bismuto; E Gratton; D C Lamb
Journal:  Biophys J       Date:  2001-12       Impact factor: 4.033

2.  Protein stability induced by ligand binding correlates with changes in protein flexibility.

Authors:  María Soledad Celej; Guillermo G Montich; Gerardo D Fidelio
Journal:  Protein Sci       Date:  2003-07       Impact factor: 6.725

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.